Characterization of Saccharomyces cerevisiae CYP61, Sterol Δ22-Desaturase, and Inhibition by Azole Antifungal Agents
Open accessThe DOI matches its Crossref record.
Abstract
Cytochrome P-45061 (CYP61) was a cytochrome P-450 revealed during the yeast genome project when chromosome XIII was sequenced. Here we report on the properties of this second microsomal P-450 of vegetatively growing yeast. The enzyme kinetics associated with its endogenous role in sterol Delta22-desaturation revealed a Km of 20.4 microM and a Vmax of 2.9nmol/min/nmol CYP61. The affinity of the enzyme for antifungal drugs was characterized to investigate its potential role in determining tolerance to these sterol 14alpha-demethylase (CYP51) inhibitors. Drug binding induced a type II spectral change, which became saturated at equimolar concentrations of azole drug and P-450. Fluconazole exhibited slightly reduced affinity in comparison to ketoconazole as indicated by carbon monoxide displacement. These and Ki determination for fluconazole (0.14 nM) revealed CYP61 to have a similar affinity to azole drugs when compared with data available for CYP51, and the implications for antifungal treatment were considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 12
- Barrell, 1995, Direct submission to EMBL/Genebank/DDBJ data base, accession number Z49211
- Yoshida, 1984, J. Biol. Chem., 259, 1655, 10.1016/S0021-9258(17)43458-2 · DOI
- Kalb, 1987, DNA, 6, 529, 10.1089/dna.1987.6.529 · DOI · Paper page
- Hata, 1981, Biochem. Biophys. Res. Commun., 103, 272, 10.1016/0006-291X(81)91689-2 · DOI
- Kelly, 1995, FEBS Lett., 377, 217, 10.1016/0014-5793(95)01342-3 · DOI
- Kelly, 1993, Biochem. Soc. Trans., 21, 1035
- Wiggins, 1984, Pestic. Sci., 15, 206, 10.1002/ps.2780150212 · DOI
- Aoyama, 1984, J. Biol. Chem., 259, 1661, 10.1016/S0021-9258(17)43459-4 · DOI · Paper page
- Hitchcock, 1990, Biochem. J., 266, 475, 10.1042/bj2660475 · DOI · Paper page
- Vanden Bossche, 1987, Pestic. Sci., 21, 289, 10.1002/ps.2780210406 · DOI
- Ragsdale, 1975, Biochim. Biophys. Acta, 380, 81, 10.1016/0005-2760(75)90047-8 · DOI
- Skaggs, 1996, Gene (Amst.), 169, 105, 10.1016/0378-1119(95)00770-9 · DOI
Cited by
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms
Lepesheva, G. I., & Waterman, M. R. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.018 · Cited by 474
Mechanisms of Cytochrome P450-Catalyzed Oxidations
Guengerich, F. P. (2018) · ACS Catalysis · doi:10.1021/acscatal.8b03401 · Cited by 453
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Cytochrome P450 enzymes in the fungal kingdom
Črešnar, B., & Petrič, Š. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.020 · Cited by 394
Reactive Oxygen Species-Inducing Antifungal Agents and Their Activity Against Fungal Biofilms
Delattin, N., Cammue, B. P., & Thevissen, K. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.189 · Cited by 189
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-10 · Cited by 165
“Because the fungistatic sterol 14 -methyl-3,6-diol (1) was not observed to accumulate in CA108 following treatment with fluconazole (Table 1), it was initially reasoned that the mutant Erg5p might function as an azole-binding cytochrome P450 that sequesters free azole away from the target Erg11p (6, 7), thus allowing…”
BackgroundSelf-citationRosenfeld, E., & Beauvoit, B. (2003) · Yeast · doi:10.1002/yea.1026 · Cited by 149
Wang, H., Kong, F., Sorrell, T. C., Wang, B., McNicholas, P., Pantarat, N., Ellis, D., Xiao, M., Widmer, F., & Chen, S. C. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-167 · Cited by 58
Sun, X., Wang, W., Wang, K., Yu, X., Liu, J., Zhou, F., Xie, B., & Li, S. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00127 · Cited by 37
Membrane Rafts Are Involved in Intracellular Miconazole Accumulation in Yeast Cells
François, I. E. J. A., Bink, A., Vandercappellen, J., Ayscough, K. R., Toulmay, A., Schneiter, R., van Gyseghem, E., Van den Mooter, G., Borgers, M., Vandenbosch, D., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014571 · Cited by 30
A role for MGA2, but not SPT23, in activation of transcription of ERG1 in Saccharomyces cerevisiae
Rice, C., Cooke, M., Treloar, N., Vollbrecht, P., Stukey, J., & McDonough, V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.020 · Cited by 12
Metadata
- Authors
- Kelly, S. L., Lamb, D. C., Baldwin, B. C., Corran, A. J., & Kelly, D. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-04
- Volume
- 272
- Issue
- 15
- Pages
- 9986-9988
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2058624667
- Cited by
- 145
- References
- 0
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 8593 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.